Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report-Reference-Cited by-同舟云学术

Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report

Published:2022-07-25 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Makrilakis Konstantinos,Barmpagianni Aikaterini,Veiga-da-Cunha Maria

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference20 articles.

1. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes;Chou JY;J Inherit Metab Dis,2015

2. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics;Kishnani PS;Genet Med,2014

3. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor;Dale DC;Curr Opin Hematol,2019

4. Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1;Visser G;Eur J Pediatr,2002

5. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length;Li AM;Pediatr Hematol Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Dependent Glucose Transporter Type 2 Inhibitors as a Breakthrough in Neutropenia and Neutrophil Dysfunction Management in Patients with Glycogen Storage Disease Type Ib;Current Pediatrics;2024-07-12

2. Case report: The success of empagliflozin therapy for glycogen storage disease type 1b;Frontiers in Endocrinology;2024-06-11

3. Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin;Blood Advances;2024-05-31

4. Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop;Molecular Genetics and Metabolism;2024-03

5. Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin;Pediatric pharmacology;2023-11-17